Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States.
- Sector(s): Healthcare
- Industry: Biotechnology
- Full Time Employees: 89
- Founded in 2014
- Headquartered in Dallas, Texas
- https://www.vaxxinity.com
Vaxxinity opened at $16.90 after pricing downsized 6.0 mln share IPO at $13/share, below the $14-$16 expected range
No comments:
Post a Comment